期刊文献+

乳腺癌髓系来源抑制细胞与外周血单核细胞的相关性及对预后的影响 被引量:1

Correlation between myeloid-derived suppressor cells and peripheral blood monocytes counts in breast cancer and its effect on prognosis
下载PDF
导出
摘要 目的探讨乳腺癌术后患者肿瘤浸润髓系来源抑制细胞(MDSCs)与外周血白细胞的相关性及对术后无复发生存时间(RFS)的影响。方法收集32例接受根治性手术的乳腺癌患者的临床病理资料及肿瘤浸润MDSCs比例,分析不同临床病理特征患者MDSCs比例差异。Spearman相关分析MDSCs与外周血白细胞的关系。根据MDSCs中位数将患者分为高MDSCs组(≥4.4%,16例)和低MDSCs组(<4.4%,16例),分析2组患者RFS的差异。结果不同临床病理特征患者中,仅Ⅲ期乳腺癌患者肿瘤浸润MDSCs比例高于Ⅰ~Ⅱ期患者(P<0.05)。肿瘤浸润MDSCs比例与外周血单核细胞计数、单核细胞/淋巴细胞比值(MLR)呈正相关(rs分别为0.405、0.408,均P<0.05)。总体分析结果显示,高、低MDSCs组RFS分别为(102.7±9.1)个月、(107.9±8.3)个月,差异无统计学意义(Log-rankχ2=1.166,P>0.05);分层分析结果显示,在17例无淋巴结转移患者中,高MDSCs组RFS明显较低MDSCs组缩短[平均RFS分别为(97.4±31.9)个月、(117.8±15.9)个月,Log-rankχ2=5.402,P<0.05]。结论乳腺癌肿瘤浸润MDSCs比例与外周血单核细胞计数、MLR呈正相关,无淋巴结转移患者高MDSCs组RFS更差。 Objective To investigate the correlation between tumor infiltrating myeloid-derived suppressor cells(MDSCs)and peripheral blood leukocytes in patients with breast cancer,and its effect on the relapse-free survival(RFS).Methods The clinical data and the proportion of tumor infiltrating MDSCs of 32 patients with breast cancer who underwent radical surgery in Tianjin Cancer Hospital were collected.The relationship between MDSCs and clinicopathological features was analyzed.The correlation between MDSCs and peripheral blood leukocytes was observed by Spearman correlation analysis.The patients were divided into the high MDSCs group(≥4.4%,n=16)and the low MDSCs group(<4.4%,n=16)according to the median MDSCs.The difference of RFS between the two groups was analyzed.Results The proportion of tumor infiltrating MDSCs was higher in patients with stageⅢthan that of patients with stageⅠ-Ⅱ(P<0.05).The proportion of MDSCs infiltrated by tumor was positively correlated with peripheral blood monocyte count(rs=0.405)and monocyte to lymphocyte ratio(MLR)(rs=0.408,P<0.05).Overall analysis results showed that RFS values of the high and low MDSCs groups were[(102.7±9.1)months and(107.9±8.3)months],and there was no significant difference between the two groups(Log-rankχ2=1.166,P>0.05).Stratified analysis showed that in 17 cases without lymph node metastasis RFS was significantly shorter in the high MDSC group[(97.4±31.9)months]than that of the low MDSCs group[(117.8±15.9)months,Log-rankχ2=5.402,P<0.05].Conclusion The proportion of MDSCs infiltrating in breast cancer is positively correlated with peripheral blood monocyte count and MLR.Patients without lymph node metastasis have worse RFS in the high MDSCs group.
作者 杜伟娇 张家丽 于文文 沈梦 曹水 DU Weijiao;ZHANG Jiali;YU Wenwen;SHEN Meng;CAO Shui(Department of Biotherapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Key Laboratory of Cancer Immunology and Biotherapy,Tianjin,Tianjin 300060,China)
出处 《天津医药》 CAS 北大核心 2022年第7期734-738,共5页 Tianjin Medical Journal
基金 天津市教委科研计划资助项目(2019KJ185)。
关键词 乳腺肿瘤 单核细胞 髓系来源抑制细胞 无复发生存时间 breast neoplasms monocytes myeloid derived suppressor cells recurrence free survival time
  • 相关文献

参考文献3

二级参考文献18

  • 1İbrahim Mungan,Çilem Bayındır Dicle,Şerife Bektaş,Sema Sarı,Serdar Yamanyar,MineÇavuş,Sema Turan,Erdal Birol Bostancı.Does the preoperative platelet-tolymphocyte ratio and neutrophil-tolymphocyte ratio predict morbidity after gastrectomy for gastric cancer?[J].Military Medical Research,2020,7(4):384-390. 被引量:13
  • 2Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorabicin-eyclophosphamide chemotherapy [ J ].Cancer Immunol Immunother, 2009, 58( 1 ) : 49-59.
  • 3Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: Linking inflammation and cancer [J]. J Immunol, 2009, 182 (8) : 4499-4506.
  • 4hiu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, et al. Population alterations of L: -arginase- and inducible nitric oxide synthase-expressed CDllb ( + )/CD14 (-)/CD15 ( + )/ CD33 ( + ) myeloid-derived suppressor cells and CD8 ( + ) T lymphocytes in patients with advanced-stage non-small cell lung cancer [ J ]. J Cancer Res Clin Oncol, [ 2010-03-09 ]. http :// www. ncbi. nlm. nih. gov/pubmed.
  • 5Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Ktibler H, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma [ J ]. Clin Cancer Res, 2008, 14(24) : 8270-8278.
  • 6Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor ceils as regulators of the immune system [ J]. Nat Rev Immunol, 2009, 9 (3) : 162-174.
  • 7Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity [ J ]. Blood, 2008, 111 ( 8 ) : 4233-4244.
  • 8Youn JI, Nagaraj S, Collazo M, Gabrilovich DI, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice [ J ]. J Immunol, 2008, 181(8): 5791-5802.
  • 9Ko JS, Zea All, Rini BI, Ireland JL, Elson P, Cohen P, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients [ J]. Clin Cancer Res, 2009, 15(6) : 2148-2157.
  • 10Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine [J]. J Clin Oncol, 2007, 25(18): 2546-2553.

共引文献31

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部